Skip to playerSkip to main content
Almost all of the raw material behind the world's most common antibiotic comes from one country — and in 2016, a single factory explosion proved what happens when that one source goes offline. This is the story of how the antibiotic supply chain became this concentrated, what's confirmed vs. what's contested about the risk, and what governments are (slowly) doing about it.

#SupplyChain #Antibiotics #China #Pharmaceuticals #Geopolitics #GlobalHealth #Documentary #Medicine #NationalSecurity #HealthNews

Category

🤖
Tech
Transcript
00:00Somewhere in your medicine cabinet, there's probably a bottle of amoxicillin.
00:04Maybe from the last time you had a sinus infection, or your kid had an ear infection.
00:10It's the most ordinary drug in the world, cheap, boring, everywhere.
00:15Here's the part that isn't boring, almost none of it starts in a factory you've ever heard of,
00:20in a country most patients never think about.
00:23According to the US-China Economic and Security Review Commission's 2026 manufacturing update,
00:29China controls the raw or key starting materials for roughly 94% of the world's amoxicillin.
00:35Not, a lot of it. 94%.
00:39This is the story of how one country ended up holding the base ingredient for the world's most used antibiotic,
00:45and what happens the day that supply doesn't show up.
00:49Every pill has two parts most people never separate in their heads,
00:53the active ingredient that actually does something to your body, and everything else,
00:57the filler, the coating, the shape.
Comments
Chronicle Insights Media
Creator
A single fermentation chemical made almost nowhere but China sits underneath most of the world's penicillin-class antibiotics — and it's already broken supply once.

Recommended